Kirjoita osake tai kryptovaluutta hakupalkkiin saadaksesi yhteenvedon
Strides Pharma Science Limited
STARStrides Pharma Science Limited develops, manufactures, and sells pharmaceutical products in Africa, Australia, North America, Europe, Asia, India, and internationally. It operates through two segments, Pharmaceutical and Biopharmaceutical. The company offers pharma generics in various forms, such as tablets, hard and soft gelatin capsules, sachets, and liquids, as well as nasal spray, gels, powders, solids, ointments, and creams. It also develops branded generics products for the treatment of chronic therapies, including women's health, central nervous system, cardiovascular, diabetes, dermatology, and probiotics under the Renerve, Unibrol, Combiart, Duotab, and Vitafer brands; and anti-retroviral, anti-malarial, anti-tuberculosis, Hepatitis, and other infectious disease drug segments for institutional business. The company was formerly known as Strides Shasun Limited and changed its name to Strides Pharma Science Limited in July 2018. Strides Pharma Science Limited was incorporated in 1990 and is headquartered in Bengaluru, India. Address: Strides House, Bengaluru, India, 560076
Analytics
WallStreetin tavoitehinta
158 475.75 INRP/E-suhde
80Osinkotuotto
0.18 %Kuluva vuosi
Edellinen vuosi
Nykyinen vuosineljännes
Viimeinen vuosineljännes
Kuluva vuosi
Edellinen vuosi
Nykyinen vuosineljännes
Viimeinen vuosineljännes
Avainluvut STAR
Osinkoanalytiikka STAR
Osinkojen kasvu 5 vuoden aikana
-25 %Jatkuva kasvu
1 vuosiMaksusuhde 5 vuoden keskiarvo
23 %Osinkohistoria STAR
Osakkeen arvostus STAR
Talousasiat STAR
Tuloksia | 2019 | Dynamiikka |